Home
Conditions
Urinary Bladder, Overactive

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

602 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

IVES for Treatment of UUI and OAB

NCT02992509

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Loma Linda University Health Loma Linda, California, United States

View Trial Details

Completed

Efficacy and Safety of Gabapentin in Treating Overactive Bladder

NCT01486706

Conditions: Detrusor Uninhibited Activity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Comprehensive Pelvic Floor Center- St. Luke's Medical Center Quezon City, National Capital Region, Philippines

View Trial Details

Completed

Utilization of the BIOWAVE Device to Treat Overactive Bladder

NCT01848366

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: William Beaumont Hospital Royal Oak, Michigan, United States

View Trial Details

Completed

Long-Term Specified Drug Use-results Survey of Betanis Tablets

NCT01901120

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Chūbu, Chubu, Japan

Chugoku, Japan

Hokkaido, Japan

Kansai, Japan

View Trial Details

Completed

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

NCT01850706

Conditions: Detrusor Overactivity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: North Shore University Hospital Manhasset, New York, United States

View Trial Details

Completed

Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder

NCT02673047

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Site D'Aix En Provence Aix-en-Provence, France

CL Toulouse Lautrec Albi, France

CHU Angers Angers, France

CH Angouleme Angoulême, France

View all 50 locations

View Trial Details

Completed

Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?

NCT02540798

Conditions: Anxiety, Anxiety Disorders, Female Urogenital Diseases, +17 more
Locations: Sandwell and West Birmingham Hospitals NHS Trust Birmingham, United Kingdom

View Trial Details

Completed

Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers

NCT02940314

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Not specified

View Trial Details

Completed

Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.

NCT02377765

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Liverpool Women's Hospital Liverpool, United Kingdom

View Trial Details

Completed

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

NCT02010788

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Urinary Bladder, Overactive

Urinary Bladder, Overactive trial results

Related conditions